Research Drops
User access blocked by platform
Florinda Ashbridge · August 4, 2026
Oncologists face insurance delays and logistical hurdles blocking access to advanced cancer treatments like CAR T-cell therapy.
01
02
03
04
05
Pharmacy oncology is reshaping cancer care as Minnesota leaders tackle operational and financial hurdles to expand outpatient bispecific antibody and CAR T‑cell
Oncologists face insurance delays and logistical hurdles blocking access to advanced cancer treatments like CAR T-cell therapy.
Experts discuss barriers to obesity care access and explore policy solutions for ensuring consistent patient treatment options are…
Vitamin D deficiency linked to kidney disease affects bone health, blood pressure, immune function and survival, revealing a…
Pharmacy oncology is reshaping cancer care as Minnesota leaders tackle operational and financial hurdles to expand outpatient bispecific…
The multiple myeloma trial reveals an 89% lower risk of disease progression or death with the teclistamab‑talquetamab combo,…
CDC links thousands of Cyclospora outbreak cases to Taco Bell lettuce. Follow the latest updates on the foodborne…
Patients with MASLD or MASH face higher risks of mild cognitive impairment. Learn about the latest study linking…
FDA rejects Capricor's deramiocel for Duchenne muscular dystrophy treatment due to lack of effectiveness evidence, based on phase…
Breast cancer care access improves with new geriatric oncology clinics like the University of Colorado Anschutz, coordinating specialists…
Wildfire smoke asthma risk rises as dense plumes degrade air quality across the Pacific Northwest, prompting emergency health…
